Savvy Updates, 12/2/24: Embecta Discontinues FDA-Approved Insulin Patch Pump, Levothyroxine & Bone Loss, Skin Patch to Measure Blood Pressure, eddii Virtual Diabetes Care

Savvy Updates, 12/2/24: Embecta Discontinues FDA-Approved Insulin Patch Pump, Levothyroxine & Bone Loss, Skin Patch to Measure Blood Pressure, eddii Virtual Diabetes Care

Dec 2, 2024 | Diabetes Business, Featured, Research News, Technology Updates

Embecta discontinues insulin patch pump development by Elise Reuter for MedTechDive.com, 26 November 2024. Embecta said it will cancel its insulin patch pump program just months after receiving clearance from the Food and Drug Administration for its first product. The...
Savvy Updates, 11/25/24: FDA Petition to Approve Sotagliflozin, Dexcom & Oura, Late Eating Alters BG Levels, PharmaSens Insulin Pumps, FDA Approves Medtronic InPen Smart Insulin Pen, PBMs sue FTC over Insulin Litigation

Savvy Updates, 11/25/24: FDA Petition to Approve Sotagliflozin, Dexcom & Oura, Late Eating Alters BG Levels, PharmaSens Insulin Pumps, FDA Approves Medtronic InPen Smart Insulin Pen, PBMs sue FTC over Insulin Litigation

Nov 25, 2024 | Advocacy, Diabetes Business, Eating, Featured, Research News, Technology Updates, Videos

In this week’s issue of The Savvy Diabetic:  FDA Petition to Approve Sotagliflozin Dexcom & Oura Late Eating Alters BG Levels PharmaSens NEW Insulin Pumps FDA Approves Medtronic InPen Smart Insulin Pen PBMs sue FTC over Insulin Litigation YOU...
Savvy Updates, 11/11/24: Rotate Infusion Sites, Dawn Phenomenon, Hidden Disabilities Sunflower, Insulin Resistence, US Diabetes Rates Rise, Companion Cards/Diabetes By Design

Savvy Updates, 11/11/24: Rotate Infusion Sites, Dawn Phenomenon, Hidden Disabilities Sunflower, Insulin Resistence, US Diabetes Rates Rise, Companion Cards/Diabetes By Design

Nov 11, 2024 | A Little Humor, Diabetes Business, Featured, Research News

Location, location, location. Does cannula site affect AID performance? by Tim Street for Diabettech.com, 7 November 2024. Rotate your injection or infusion sites. That’s a key message that anyone living with type 1 is delivered very early in their life with the...
Savvy Updates, 11/4/24: O5/iPhone, Abbott CGM & MRIs, FDA Rejects Sotagliflozin, Chinese Stem-Cell Therapies, Semaglutide & Arthritis, Beta Bionics & Libre 3 Plus, AI & Diabetic Cardiomyopathy, Insulcloud & Insulin Pens, Dexcom CCO Retires

Savvy Updates, 11/4/24: O5/iPhone, Abbott CGM & MRIs, FDA Rejects Sotagliflozin, Chinese Stem-Cell Therapies, Semaglutide & Arthritis, Beta Bionics & Libre 3 Plus, AI & Diabetic Cardiomyopathy, Insulcloud & Insulin Pens, Dexcom CCO Retires

Nov 4, 2024 | Advocacy, Diabetes Business, Featured, Research News, Technology Updates

In this week’s issue of The Savvy Diabetic:  Omnipod 5 & the iPhone App Abbott CGM Sensors OK in MRI FDA Rejects Sotagliflozin for T1D Chinese Stem Cell-Based Therapies Semaglutide for Knee Osteoarthritis Pain Beta Bionics Launches iLet with Abbott...
Savvy Updates: 10/28/24: Insulin for BG Drops, Luna Diabetes Pivotal Trial, Levicure’s Triple-Combo Therapy, T1D GLP-1/SGLT2 Use, DTS Innovations, Semaglutide/T1D/Alzheimer’s, Hospitalizations by Age, Insurance Companies’ Woes

Savvy Updates: 10/28/24: Insulin for BG Drops, Luna Diabetes Pivotal Trial, Levicure’s Triple-Combo Therapy, T1D GLP-1/SGLT2 Use, DTS Innovations, Semaglutide/T1D/Alzheimer’s, Hospitalizations by Age, Insurance Companies’ Woes

Oct 28, 2024 | Diabetes Business, Featured, Research News, Technology Updates

In this week’s issue of The Savvy Diabetic:  New Insulin to Prevent Sudden BG Drops Luna Diabetes Clinical Trial for AID Closed-Loop for MDI Levicure’s Triple-Combo Oral Therapy to Restore Insulin Production GLP-1, SGLT2 Drug Scripts on the Rise...
Skip to content